Reduced p16 and Increased Cyclin D1 and pRb Expression Are Correlated With Progression in Cutaneous Melanocytic Tumors
- 10 August 2009
- journal article
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 17 (5), 361-367
- https://doi.org/10.1177/1066896909336177
Abstract
The immunohistochemical expression of cell cycle proteins p16, cyclin D1, and pRb was assessed in 112 benign and malignant melanocytic tumors and correlated with tumor progression, prognosis, and outcome. Comparing benign and malignant tumors, there were significant differences in the median score for all 3 proteins, with decreased p16 (P = .000001), increased cyclin D1 (P = .01), and increased pRb in melanomas (P = .01). There was a progressive loss of expression of p16 with progression from benign naevi to primary melanomas and to metastases. p16 was significantly decreased in primary tumors from melanoma patients who developed recurrent disease (P = .0000013). Cyclin D1 and pRb showed a progressive increase in expression from benign to malignant tumors but with relative decreases in the more advanced tumors (thick primaries and metastatic melanomas). Alterations in cell cycle proteins involved in G1/S transition are implicated in melanocytic tumor progression and have a potential role in diagnosis and prognostication.Keywords
This publication has 24 references indexed in Scilit:
- Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cellsOncogene, 2006
- The role of cell cycle regulatory proteins in the pathogenesis of melanomaPathology, 2006
- Biochemical and cellular mechanisms of mammalian CDK inhibitors: a few unresolved issuesOncogene, 2005
- Adhesion control of cyclin D1 and p27Kip1 levels is deregulated in melanoma cells through BRAF-MEK-ERK signalingOncogene, 2005
- Progression in Cutaneous Malignant Melanoma Is Associated with Distinct Expression ProfilesThe American Journal of Pathology, 2004
- Cell cycle regulators: role in etiology, prognosis and treatment in cancerAnnals of Oncology, 2002
- Downregulation of the Retinoblastoma Gene Expression in the Progression of Malignant MelanomaPathobiology, 2001
- Analysis of G1/S checkpoint regulators in metastatic melanomaGenes, Chromosomes and Cancer, 2000
- Understanding the cell cycleNature Medicine, 1998
- Cell Cycle Control and CancerScience, 1994